AzTrials
AzTrials

Perioperative Neurocognitive DisordersNCT06028568

The Reliability and Validity of Perioperative Cognitive Test Network Platform for Monitoring Neurocognitive Changes

An observational study of Perioperative Neurocognitive Disorders, run by Xijing Hospital.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aimed to analyze the reliability and validity of the results of the new designed perioperative cognitive test network platform, and to judge the reliability and scientific nature of the perioperative cognitive test. Read more about this study

Who is it for?
Ages 65 years and olderHealthy volunteers can take part
Conditions the study is for
Perioperative Neurocognitive Disorders
How many people
400 participants
Where
No sites listed yet
Study dates
1 Oct 2023to 31 Mar 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Study population: This study will include two groups: elderly healthy volunteers and elderly patients undergoing abdominal surgery.

Who may be able to join

  • Age over 65
  • Scheduled for abdominal surgery under general anesthesia (grade 3-4 surgery based on surgical grade)
  • Informed consent has been obtained
  • Healthy volunteer groups are listed as age-and sex-matched community groups

Who cannot join

  • Unable to follow instruction and finish the firtst procedure
  • Has severe visual or auditory problems
  • History of drug or alcohol abuse (drinking more than 5U daily in the past 3 months, 1U equals 10ml or 8g pure alcohol, equivalent to >50 liquor over 100ml, two two
  • Are diagnosed neuropsychological disease that needs treatment
  • Clear history of severe cerebrovascular diseases (including cerebral hemorrhage and cerebral infarction), Parkinson's syndrome, schizophrenia, bipolar disorder, depression, dementia, Alzheimer's disease, etc
  • Severe head trauma, carbon monoxide poisoning and other loss of consciousness more than 30 minutes
  • MMSE score ≤23
  • Participated this study or being participating other clinical research

Trial locations and contacts

No sites are listed yet.

Zhixin Wu, physician contact

18392187971

wuzhixin212@163.com

About this study

Official title: The Reliability and Validity of Perioperative Cognitive Test Network Platform for Monitoring Perioperative Neurocognitive Function Changes in Patients Undergoing Surgery

This study aimed to analyze the reliability and validity of the results of the new designed perioperative cognitive test network platform, and to judge the reliability and scientific nature of the perioperative cognitive test. And then to explore whether the perioperative cognitive test network platform can be used to evaluate the changes of perioperative cognitive function of patients.

Read the detailed description

Two cohorts of elderly healthy volunteers and elderly patients undergoing abdominal surgery will be included in this study. The cognitive function of the patients was tested one day before and seven days after operation. Healthy volunteers had two cognitive function tests at the same interval. The normality test is used to evaluate whether the test results accord with the normal distribution. The internal consistency of the test was evaluated by calculating the Cronbach coefficient, the content validity was evaluated by experts and the content validity index was calculated, and the construct validity of the test was evaluated by exploratory factor analysis and confirmatory factor analysis. The validity of the test was evaluated by calculating the effect scale.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06028568
Study groupRoleWhat they receive
Elderly patients undergoing surgeryOlder than or equal to 65 years of age; patients who intend to undergo major abdominal surgery under general anesthesia (grade 3-4 surgery based on surgical grade)
Elderly healthy volunteersAge-and sex-matched community population

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Reliability

    Cronbach's alpha is used to assess the reliability and the internal consistency of this Cognitive test.

    Cronbach's alpha value >0.7 indicating the reliability of the test is acceptable.

    Measured: Baseline Test:1 day before operation, Second Test: Day 7 after operation

  2. Validity

    Content validity, Construct validity and Responsiveness analysis are used to evaluate the validity of the cognitive test.

    The item-content validity index (I-cvi) is used evaluate the Content validity. I-cvi≥ 0.78 means the content validity is satisfactory.

    The Exploratory Factor Analysis (EFA) is used evaluate the Construct validity. The Kaiser-Mayer-Olkin (KMO) index (>0.6) is used to evaluate adaptability for factor analysis. Factor loading should >0.4.

    The Responsiveness analysis is used to evaluate the ability of this cognitive test that can reflect the change of cognitive function of the Interviewer during operation. Paired t-test can be used to compare whether the difference in score before and after is statistically significant. P value should < 0.05.

    Measured: Baseline Test:1 day before operation, Second Test: Day 7 after operation

Secondary outcomes (1)
  1. PND (Perioperative neurocognitive disorders)

    PND is diagnosed by calculating the Z-score. The investigators get the score or accuracy and completion time of each test through the cognitive test network platform.

    Then Calculate Z-score: For each test, the mean practice effect is subtracted from the difference between preoperative and postoperative test scores; the result is then divided by the control group standard deviation to obtain a z-score. The z-scores of all tests in an individual patient are summarized and divided by the standard deviations for this sum of z-scores in the control subjects, creating a composite z-score.

    Cognitive decline is defined when two z-scores in individual tests or the composite z-score ≤-1.96.

    Perioperative neurocognitive disorders (PND) mainly refer to neurocognitive decline detected after surgery and anesthesia.

    Measured: Baseline Test:1 day before operation, Second Test: Day 7 after operation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Sep 2023
  2. Study start1 Oct 2023 (estimated)
  3. Primary completion31 Dec 2023 (estimated)
  4. Study completion31 Mar 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Ecologic or community
Time perspective
Prospective
Enrolment
400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06028568
Sponsor's protocol ID
KY20232188-C-1
Status last verified
Jun 2023
First submitted
7 Jul 2023
Last updated
14 Sep 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Perioperative Neurocognitive Disorders, run by Xijing Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Zhixin Wu, physician (18392187971, wuzhixin212@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Reliability (time frame: Baseline Test:1 day before operation, Second Test: Day 7 after operation). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Sep 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in